DLBCLone: A unified framework for neighbourhood-based genetic subtyping of lymphomas
Klossok, L.; Dreval, K.; Cruz, M.; Gillis, S.; Wong, J.; Collinge, B.; Steidl, C.; Scott, D. W.; Hilton, L.; Morin, R. D.
Show abstract
Genetic subtyping of diffuse large B-cell lymphoma (DLBCL) has been slow to gain clinical adoption. Available classifiers either leave many tumours unclassified or depend on exome-wide features and copy-number profiles, which are not always available in routine practice. We introduce DLBCLone, a neighbourhood-based framework that enables panel-aware genetic subtyping compatible with existing taxonomies. DLBCLone learns a 2-D reference map of mutation profiles (UMAP) from a labeled training cohort, freezes this map, and deterministically projects new cases into the same latent space. Class labels are then inferred by weighted K-nearest neighbours, limiting over-assignment by considering the local density of unclassified neighbours. By default, classification thresholds optimize per-class balanced accuracy, but can be adjusted to suit study needs. The framework is intended to emulate (or "clone") existing schemas such as LymphGen or DLBClass. Trained on a harmonized cohort of 2,130 DLBCLs, DLBCLone classifiers for different gene panels achieved consistently improve classification rates relative to fixed-threshold baselines while maintaining a reasonable per-class performance. On an in-house cohort of 323 patients, it assigned an additional 98 samples without compromising accuracy relative to LymphGen. On an external exome-sequenced subset from a 1,001-patient cohort, DLBCLone achieved a 51% classification rate (vs 36% for LymphGen) at an overall accuracy of 0.70. Compared with another LymphGen approximator (LymphPlex), DLBCLone reached a 74% classification rate (vs 55%). In general, the DLBCLone-reclassified tumours had molecular features consistent with their new labels. DLBCLone provides a deterministic, reproducible, and extensible approach to genetic subtyping under real-world constraints, facilitating prospective studies that rely on either targeted panels or more comprehensive sequencing strategies. DLBCLone is open source and available in the GAMBLR.predict package (https://github.com/morinlab/gamblr.predict).
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Generalizing AI-driven Assessment of Immunohistochemistry across Immunostains and Cancer Types: A Universal Immunohistochemistry Analyzer 94%
- Deep learning inference of cell type-specific gene expression from breast tumor histopathology 93%
- MatchMiner: An open source platform for cancer precision medicine 93%
Similar papers in this journal
- Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma 94%
- Coding and regulatory drivers of mantle cell lymphoma identified through exome and genome sequencing 93%
- Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression between patients 91%
Similar papers in this journal
Similar papers in this journal
- Knowledge transfer to enhance the performance of deep learning models for automated classification of B-cell neoplasms 93%
- Obtaining Spatially Resolved Tumor Purity Maps Using Deep Multiple Instance Learning In A Pan-cancer Study 93%
- Federated Learning for multi-omics: a performance evaluation in Parkinson's disease 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.